Media contacts:

Maureen Collins
202-326-1804
maureen.collins@edelman.com

Pat Adams
703-606-2365
padams@npcnow.org

Dan Leonard to Lead National Pharmaceutical Council

New President Joins as NPC Addresses Evidence-Based Medicine

Reston, Va., March 24, 2008 – The National Pharmaceutical Council (NPC) announced
that Dan Leonard has been appointed as its new president. As the leader of NPC, he
will guide the organization as it adopts evidence-based medicine (EBM) as a new
priority within its existing mission of advancing research on the appropriate use of
prescription medicines. Leonard replaces Karen Williams, who has served as president
since 1996.

NPC collaborates with key stakeholders to develop the science base needed to inform
key health care discussions. Under Leonard’s leadership, NPC will leverage its
distinctive position to grow its focus on evidence-based medicine, while continuing to
sponsor and participate in other research and education about the clinical and economic
value of pharmaceuticals. Leonard will also be responsible for recruiting staff with the
clinical, scientific and methodological expertise necessary to advance evidence-based
decision-making.

“The NPC Board is pleased to welcome Dan as the new leader of the organization,”
said Paul Fonteyne, executive vice president of Boehringer-Ingelheim Pharmaceuticals
and current NPC board chairman. “He brings a depth and breadth of experience in
association leadership, public affairs and strategic communications that are critical for
advancing the organization’s mission.”

Leonard comes to NPC from America’s Health Insurance Plans (AHIP), where he most
recently served as the executive vice president of advocacy and professional services
and ran the legislative affairs, strategic communications and professional education
departments. Leonard also worked closely with the AHIP Board of Directors and senior
management team to guide the organization through the dynamic changes associated
with the merger between the American Association of Health Plans (AAHP) and the
Health Insurance Association of America (HIAA) that created AHIP.

For more than 50 years, NPC has provided research and education to give key
decision-makers reliable information on which to base policy decisions. “I am delighted
and honored to have the opportunity to lead NPC in fulfilling its mission,” said Leonard.

National Pharmaceutical Council1984 Preston White Drive, Reston, VA 20191-5433 www.npcnow.org

“NPC’s priority of helping enhance the quality of evidence and its application to health
care decision-making is timely and important. I share the Board’s commitment to a
strong science base as a critical component in ensuring the best possible patient health
outcomes. Through our work at NPC and our collaborations with others in the coming
months, we hope to advance the science of evidence-based medicine and contribute to
practical solutions that will benefit patients.”

NPC’s focus on evidence-based medicine builds on the organization’s long history of

working with researchers, patients, medical professionals and payers, including
employers and government officials. Recent NPC work on EBM has included
engagement with the Institute of Medicine Roundtable on Evidence-Based Medicine, the
Agency for Healthcare Research and Quality (AHRQ) and the Health Industry Forum. In
pursuing NPC’s new focus on EBM, Leonard will lead the organization in bringing the
pharmaceutical industry’s technical expertise and applied scientific knowledge base to
considerations of EBM, comparative effectiveness reviews, evaluation and application.

NPC was established in 1953 and is supported by approximately 20 of the nation’s

major research-based pharmaceutical companies. A prior press release from August
2007 about NPC’s new strategic focus and search for new leadership is available at
www.npcnow.org/newsroom/pressreleases/PR_NPCfocus.asp.

###